Lonza primary, diseased primary and stem cells

Wednesday, 14 March, 2012 | Supplied by: Lonza Australia Pty Ltd



Research shows that non-transformed, non-immortalised cells isolated directly from tissue provide conditions that closely simulate a living model and yield more physiologically significant results.

With Clonetics Primary Normal Cells and Media, Lonza provides over 150 authenticated primary human and animal cell types with optimised media for growth and maintenance.

With Clonetics Primary Diseased Cells, the company offers primary cells derived from patients with COPD, asthma, Type 1 and Type 2 diabetes.

The company’s Stem Cells and Media offer primary human adult stem and progenitor cells from bone marrow, cord blood and adipose tissue with growth and differentiation media, and ES-derived differentiated cells and media.

Lonza primary cells and media are tested together to guarantee performance. The company uses strict industry QC standards to ensure consistent performance on every lot manufactured.

All tissue utilised for the company’s human cell products is ethically obtained with documented and informed donor consent.

Online: www.lonza.com
Phone: 03 9550 0883
Related Products

Merck VirusExpress Lentiviral Production Platform

The platform helps to overcome lentiviral production challenges and can reduce process...

Diaclone research tools for cytokine storm monitoring

Diaclone provides a large panel of research tools, monoclonal antibodies and ELISA kits for...

BioLamina Biosilk biomaterial for 3D cell culture of hPSCs

BioLamina's Biosilk is a 3D cell culture biomaterial made from recombinant spider silk...


  • All content Copyright © 2020 Westwick-Farrow Pty Ltd